Results 171 to 180 of about 10,024 (235)

Severe COVID-19 in the Republic of Korea: Epidemiology, Risk Factors, Therapeutics, and Prognostic Models From Nationwide Data. [PDF]

J Korean Med Sci
Choi JY.
europepmc   +1 more source

Pharmacological and Adjunctive Management of Non-Hospitalized COVID-19 Patients During the Omicron Era: A Systematic Review and Meta-Analysis. [PDF]

Viruses
Rindi LV, Zaçe D, Sarmati L, Parrella R, Russo G, Andreoni M, Mastroianni CM.   +6 more
europepmc   +1 more source

Tackling emerging viral diseases with epidemic potential [PDF]

Li, Pengfei
core  

Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects. [PDF]

Drug Des Devel Ther
Lv D, Li S, Li Y, Lin M, Zhai Y, Wu M, Qiu Y, Zhao Q, Liu J.   +8 more
europepmc   +1 more source

SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study. [PDF]

Nat Commun
Chong KC, Wei Y, Jia KM, Boyer C, Lin G, Wang H, Li C, Hung CT, Jiang X, Yam CHK, Chow TY, Wang Y, Zhao S, Li K, Yang A, Mok CKP, Hui DS, Yeoh EK, Guo Z.   +18 more
europepmc   +1 more source

Respiratory Viral Infection Prophylaxis and Treatment in the Transplant Population. [PDF]

Viruses
Giuliani AAM, Chen V, Law N.
europepmc   +1 more source

Developing pan-coronavirus therapeutics:Targeting viral replication and inflammation [PDF]

Wang, Yining
core  

Molnupiravir for COVID-19.

Australian prescriber
openaire   +1 more source